Paris, Ile-de-France, France In 1946 was created INRA, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Paris. The company was established in Europe in France.
Among the most popular portfolio startups of the fund, we may highlight Exeliom. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018.
The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Sofimac Innovation, Cap Innov'Est, Biocodex.
| Fund Name | Location |
| Anhui Zhongding Sealing Parts | Anhui, China, Ningguo |
| Apple | California, Cupertino, United States |
| Augment Ventures | India, Kolkata, West Bengal |
| Beijing Hualian Group | Beijing, Beijing, China |
| Carlin Investments | California, Encino, United States |
| Foundation Holdings | Dubai, United Arab Emirates |
| FTR Ventures | Germany, Germany, Hamburg |
| G5 Capital LLC | - |
| Integra LifeSciences | New Jersey, Plainsboro, United States |
| Megala Ventures | - |
| Mercurio | - |
| Source Interlink Companies | Bonita Springs, Florida, United States |
| Tank Partners | Seguin, Texas, United States |
| Team Europe | Berlin, Berlin, Germany |
| The Lakes Charitable Foundation | - |
| The W Fund | - |
| Venturepreneurs | Barcelona, Catalonia, Spain |
| ZORA Ventures | Israel, Tel Aviv, Tel Aviv District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Exeliom | $8M | 06 Jul 2018 | Dijon, Bourgogne-Franche-Comté, France | ||
ENTEROME | $1M | 01 Jan 2011 | France, Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Exeliom | $8M | 06 Jul 2018 | Dijon, Bourgogne-Franche-Comté, France | ||
ENTEROME | $1M | 01 Jan 2011 | France, Ile-de-France |
